Vertex Pharmaceuticals Incorporated vs HDFC Bank Limited
Market cap comparison over time
Vertex Pharmaceuticals Incorporated
$133.4B
Rank #123
HDFC Bank Limited
$136.1B
Rank #121
Market Cap Over Time
Key Moments
- HDFC Bank Limited overtook Vertex Pharmaceuticals Incorporated by 2003
- Vertex Pharmaceuticals Incorporated overtook HDFC Bank Limited by 2005
- HDFC Bank Limited overtook Vertex Pharmaceuticals Incorporated by 2007
Year-by-Year Comparison
| Year | Vertex Pharmaceuticals Incorporated | HDFC Bank Limited | Leader |
|---|---|---|---|
| 2026 | $133.4B | $136.1B | HDFC Bank Limited |
| 2025 | $115.1B | $183.1B | HDFC Bank Limited |
| 2024 | $102.2B | $161.6B | HDFC Bank Limited |
| 2023 | $103.3B | $153.7B | HDFC Bank Limited |
| 2022 | $73.3B | $144.8B | HDFC Bank Limited |
| 2021 | $55.7B | $130.0B | HDFC Bank Limited |
| 2020 | $60.0B | $125.7B | HDFC Bank Limited |
| 2019 | $55.6B | $111.3B | HDFC Bank Limited |
| 2018 | $42.1B | $92.1B | HDFC Bank Limited |
| 2017 | $38.0B | $80.7B | HDFC Bank Limited |
| 2016 | $18.7B | $51.7B | HDFC Bank Limited |
| 2015 | $31.9B | $46.0B | HDFC Bank Limited |
| 2014 | $30.2B | $40.1B | HDFC Bank Limited |
| 2013 | $18.9B | $27.8B | HDFC Bank Limited |
| 2012 | $10.6B | $28.1B | HDFC Bank Limited |
| 2011 | $8.4B | $17.6B | HDFC Bank Limited |
| 2010 | $8.9B | $19.2B | HDFC Bank Limited |
| 2009 | $10.9B | $13.8B | HDFC Bank Limited |
| 2008 | $7.7B | $8.1B | HDFC Bank Limited |
| 2007 | $5.9B | $13.9B | HDFC Bank Limited |
| 2006 | $9.5B | $8.5B | Vertex Pharmaceuticals Incorporated |
| 2005 | $7.0B | $5.6B | Vertex Pharmaceuticals Incorporated |
| 2004 | $2.7B | $4.1B | HDFC Bank Limited |
| 2003 | $2.6B | $2.8B | HDFC Bank Limited |
| 2002 | $4.0B | $1.7B | Vertex Pharmaceuticals Incorporated |
| 2001 | $6.2B | $1.7B | Vertex Pharmaceuticals Incorporated |
| 2000 | $18.1B | $1.7B | Vertex Pharmaceuticals Incorporated |
| 1999 | $4.4B | $1.2B | Vertex Pharmaceuticals Incorporated |
| 1998 | $3.8B | $401.7M | Vertex Pharmaceuticals Incorporated |
| 1997 | $4.2B | $581.3M | Vertex Pharmaceuticals Incorporated |
| 1996 | $5.1B | $279.5M | Vertex Pharmaceuticals Incorporated |